
|Videos|April 24, 2017
Biosimilars in Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.
Advertisement
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia
2
Targeting CSF1R in TGCT: Evaluating the Evidence and Empowering Pharmacist-Led Care
3
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
4
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
5










































































































